Table 5 IC50 values of gilteritinib and abemaciclib measured in AML cell lines
From: Combination strategies to overcome drug resistance in FLT+ acute myeloid leukaemia
|  | Gilteritinib (nM) | Abemaciclib (µM) |
|---|---|---|
MOLM-13 | 0.99 ± 0.14 | 0.53 ± 0.18 |
MOLM-14 | 3.60 ± 0.04 | 0.24 ± 0.17 |
MV4-11 | 1.85 ± 0.06 | 3.83 ± 0.09 |